Protagonist Therapeutics Insider Trades
NASDAQ: PTGXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 39 · $96.20M
- Shares bought / sold
- 0 / 862.85K
- Net activity
- Net selling $96.2 million
Protagonist Therapeutics insider activity
Over the last 12 months, Protagonist Therapeutics insiders reported 87 transactions on SEC Form 4: 0 open-market purchases and 39 sales. Insiders bought $0 and sold $96.2 million worth of stock, for net insider selling of $96.2 million. The largest seller was PATEL DINESH V PH D, with $60.6 million in reported sales.
The most recent filing shows Ali Asif (Chief Financial Officer) reporting a transaction in 9,229 shares at $38.98 on Sep 30, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put PTGX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
PTGX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 30, 2026 | Ali AsifChief Financial Officer | Sale | 46,034 | $6.53M | Form 4 |
| Sep 30, 2026 | Ali AsifChief Financial Officer | Sale | 12,595 | $1.79M | Form 4 |
| Sep 30, 2026 | Ali AsifChief Financial Officer | Option exercise | 5,312 | $64.65K | Form 4 |
| Sep 30, 2026 | Ali AsifChief Financial Officer | Option exercise | 15,650 | $300.32K | Form 4 |
| Sep 30, 2026 | Ali AsifChief Financial Officer | Option exercise | 28,438 | $666.02K | Form 4 |
| Sep 30, 2026 | Ali AsifChief Financial Officer | Option exercise | 9,229 | $359.75K | Form 4 |
| Sep 10, 2026 | PATEL DINESH V PH DPresident and CEO | Sale | 7,278 | $1.05M | Form 4 |
| Sep 10, 2026 | PATEL DINESH V PH DPresident and CEO | Option exercise | 7,278 | $157.06K | Form 4 |
| Sep 9, 2026 | PATEL DINESH V PH DPresident and CEO | Sale | 63,548 | $9.29M | Form 4 |
| Sep 9, 2026 | PATEL DINESH V PH DPresident and CEO | Option exercise | 63,548 | $1.37M | Form 4 |
| Sep 8, 2026 | PATEL DINESH V PH DPresident and CEO | Sale | 54,174 | $7.90M | Form 4 |
| Sep 8, 2026 | PATEL DINESH V PH DPresident and CEO | Option exercise | 54,174 | $1.17M | Form 4 |
| Sep 3, 2026 | PATEL DINESH V PH DPresident and CEO | Gift | 510 | — | Form 4 |
| Aug 11, 2026 | PATEL DINESH V PH DPresident and CEO | Sale | 34,239 | $5.09M | Form 4 |
| Aug 11, 2026 | PATEL DINESH V PH DPresident and CEO | Option exercise | 34,239 | $738.88K | Form 4 |
| Aug 10, 2026 | PATEL DINESH V PH DPresident and CEO | Sale | 65,761 | $9.81M | Form 4 |
| Aug 10, 2026 | PATEL DINESH V PH DPresident and CEO | Option exercise | 65,761 | $1.42M | Form 4 |
| Jun 23, 2026 | Waddill William D.Director | Sale | 9,000 | $1.06M | Form 4 |
| Jun 23, 2026 | Waddill William D.Director | Option exercise | 9,000 | $148.86K | Form 4 |
| Jun 10, 2026 | Waddill William D.Director | Sale | 9,000 | $969.12K | Form 4 |
| Jun 10, 2026 | Waddill William D.Director | Option exercise | 6,000 | $99.24K | Form 4 |
| Jun 10, 2026 | Waddill William D.Director | Option exercise | 3,000 | $35.40K | Form 4 |
| May 29, 2026 | Waddill William D.Director | Sale | 9,000 | $896.76K | Form 4 |
| May 29, 2026 | Waddill William D.Director | Option exercise | 9,000 | $106.20K | Form 4 |
| May 12, 2026 | PATEL DINESH V PH DPresident and CEO | Sale | 75,000 | $7.51M | Form 4 |
| May 12, 2026 | PATEL DINESH V PH DPresident and CEO | Option exercise | 75,000 | $1.62M | Form 4 |
| May 12, 2026 | PATEL DINESH V PH DPresident and CEO | Sale | 75,000 | $7.51M | Form 4 |
| May 12, 2026 | PATEL DINESH V PH DPresident and CEO | Option exercise | 75,000 | $1.62M | Form 4 |
| May 8, 2026 | Giraudo BryanDirector | Sale | 5,130 | $513.00K | Form 4 |
| May 8, 2026 | Giraudo BryanDirector | Sale | 6,000 | $600.00K | Form 4 |
| May 7, 2026 | Giraudo BryanDirector | Sale | 12,000 | $1.20M | Form 4 |
| May 7, 2026 | Giraudo BryanDirector | Sale | 36,000 | $3.61M | Form 4 |
| May 7, 2026 | Giraudo BryanDirector | Option exercise | 12,000 | $83.76K | Form 4 |
| May 7, 2026 | Giraudo BryanDirector | Option exercise | 24,000 | $154.80K | Form 4 |
| Apr 23, 2026 | PATEL DINESH V PH DPresident and CEO | Gift | 1,460 | — | Form 4 |
| Apr 20, 2026 | Ali AsifChief Financial Officer | Sale | 1,750 | $184.57K | Form 4 |
| Mar 26, 2026 | Ali AsifChief Financial Officer | Sale | 24,765 | $2.58M | Form 4 |
| Mar 26, 2026 | Ali AsifChief Financial Officer | Option exercise | 5,265 | $64.08K | Form 4 |
| Mar 26, 2026 | Ali AsifChief Financial Officer | Option exercise | 19,500 | $374.20K | Form 4 |
| Mar 26, 2026 | MOLINA ARTURO MDChief Medical Officer | Sale | 15,000 | $1.57M | Form 4 |
| Mar 26, 2026 | MOLINA ARTURO MDChief Medical Officer | Option exercise | 15,000 | $120.60K | Form 4 |
| Mar 26, 2026 | SELICK HAROLD EDirector | Sale | 24,000 | $2.52M | Form 4 |
| Mar 26, 2026 | SELICK HAROLD EDirector | Option exercise | 24,000 | $309.12K | Form 4 |
| Mar 25, 2026 | PATEL DINESH V PH DPresident and CEO | Sale | 54,641 | $5.52M | Form 4 |
| Mar 25, 2026 | PATEL DINESH V PH DPresident and CEO | Option exercise | 54,641 | $468.82K | Form 4 |
| Mar 24, 2026 | PATEL DINESH V PH DPresident and CEO | Sale | 59 | $5.96K | Form 4 |
| Mar 24, 2026 | PATEL DINESH V PH DPresident and CEO | Option exercise | 59 | $506.22 | Form 4 |
| Mar 23, 2026 | PATEL DINESH V PH DPresident and CEO | Gift | 50,000 | — | Form 4 |
| Feb 17, 2026 | Williams Lewis TDirector | Sale | 18,000 | $1.48M | Form 4 |
| Feb 17, 2026 | Williams Lewis TDirector | Option exercise | 18,000 | $195.12K | Form 4 |
| Feb 6, 2026 | Waddill William D.Director | Sale | 20,000 | $1.67M | Form 4 |
| Feb 6, 2026 | Waddill William D.Director | Option exercise | 20,000 | $166.20K | Form 4 |
| Jan 27, 2026 | MOLINA ARTURO MDChief Medical Officer | Sale | 5,000 | $410.00K | Form 4 |
| Jan 27, 2026 | MOLINA ARTURO MDChief Medical Officer | Option exercise | 5,000 | $40.20K | Form 4 |
| Jan 27, 2026 | PATEL DINESH V PH DPresident and CEO | Sale | 4,068 | $338.42K | Form 4 |
| Jan 27, 2026 | PATEL DINESH V PH DPresident and CEO | Option exercise | 4,068 | $87.79K | Form 4 |
| Jan 27, 2026 | Ali AsifChief Financial Officer | Sale | 18,203 | $1.51M | Form 4 |
| Jan 27, 2026 | Ali AsifChief Financial Officer | Sale | 28,000 | $2.33M | Form 4 |
| Jan 27, 2026 | Ali AsifChief Financial Officer | Option exercise | 12,000 | $146.04K | Form 4 |
| Jan 27, 2026 | Ali AsifChief Financial Officer | Option exercise | 16,000 | $307.04K | Form 4 |
| Jan 26, 2026 | MOLINA ARTURO MDChief Medical Officer | Sale | 5,000 | $411.40K | Form 4 |
| Jan 26, 2026 | MOLINA ARTURO MDChief Medical Officer | Option exercise | 5,000 | $40.20K | Form 4 |
| Jan 26, 2026 | PATEL DINESH V PH DPresident and CEO | Sale | 14,205 | $1.19M | Form 4 |
| Jan 26, 2026 | PATEL DINESH V PH DPresident and CEO | Option exercise | 14,205 | $306.54K | Form 4 |
| Jan 26, 2026 | PATEL DINESH V PH DPresident and CEO | Sale | 10,685 | $897.54K | Form 4 |
| Jan 26, 2026 | PATEL DINESH V PH DPresident and CEO | Option exercise | 10,685 | $44.98K | Form 4 |
| Jan 23, 2026 | MOLINA ARTURO MDChief Medical Officer | Sale | 13,151 | $1.08M | Form 4 |
| Jan 23, 2026 | PATEL DINESH V PH DPresident and CEO | Sale | 19,315 | $1.63M | Form 4 |
| Jan 23, 2026 | PATEL DINESH V PH DPresident and CEO | Option exercise | 19,315 | $81.32K | Form 4 |
| Jan 23, 2026 | PATEL DINESH V PH DPresident and CEO | Gift | 6,000 | — | Form 4 |
| Jan 20, 2026 | Ali AsifChief Financial Officer | Sale | 8,588 | $708.34K | Form 4 |
| Jan 20, 2026 | PATEL DINESH V PH DPresident and CEO | Sale | 34,438 | $2.84M | Form 4 |
| Jan 20, 2026 | MOLINA ARTURO MDChief Medical Officer | Sale | 9,514 | $784.71K | Form 4 |
| Jan 9, 2026 | SELICK HAROLD EDirector | Option exercise | 14,299 | $60.20K | Form 4 |
| Jan 2, 2026 | MOLINA ARTURO MDChief Medical Officer | Award | 25,600 | — | Form 4 |
| Jan 2, 2026 | Ali AsifChief Financial Officer | Award | 25,600 | — | Form 4 |
| Jan 2, 2026 | PATEL DINESH V PH DPresident and CEO | Award | 95,400 | — | Form 4 |
| Jan 2, 2026 | Williams Lewis TDirector | Award | 2,695 | — | Form 4 |
| Jan 2, 2026 | Giraudo BryanDirector | Award | 2,695 | — | Form 4 |
| Jan 2, 2026 | Waddill William D.Director | Award | 2,695 | — | Form 4 |
| Jan 2, 2026 | O'Dowd Sarah ADirector | Award | 2,695 | — | Form 4 |
| Jan 2, 2026 | SELICK HAROLD EDirector | Award | 2,695 | — | Form 4 |
| Nov 21, 2025 | PATEL DINESH V PH DPresident and CEO | Gift | 440 | — | Form 4 |
| Nov 17, 2025 | MOLINA ARTURO MDChief Medical Officer | Sale | 2,712 | $229.90K | Form 4 |
| Oct 10, 2025 | Waddill William D.Director | Sale | 8,000 | $702.48K | Form 4 |
| Oct 10, 2025 | Waddill William D.Director | Sale | 4,000 | $277.00K | Form 4 |
| Oct 10, 2025 | Waddill William D.Director | Option exercise | 12,000 | $83.76K | Form 4 |
| Sep 22, 2025 | Waddill William D.Director | Sale | 4,000 | $257.00K | Form 4 |
| Sep 16, 2025 | PATEL DINESH V PH DPresident and CEO | Gift | 620 | — | Form 4 |
| Aug 27, 2025 | Waddill William D.Director | Sale | 4,000 | $237.00K | Form 4 |
| Jul 25, 2025 | PATEL DINESH V PH DPresident and CEO | Sale | 10,415 | $570.53K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4